Key Highlights
Annual U.S. medical office deal value has climbed from ~$29B (2016) to ~$154B (2025).
Investment is accelerating as traditional office slows and capital markets ease.
Big Sky Asset Management acquired Dallas-based HealthCap Partners (7/1) — a platform, not a building.
Multiple small MOB closings continued through early July across CA, IN, AZ and FL.
Demographics and outpatient migration underwrite the demand.
The Signal
MOB has moved from niche to core allocation.
Buyers are acquiring operating platforms, not just assets — a maturity signal.
The bid is defensive: recession-resilient, demographically driven cash flow.
Medical office has quietly become one of CRE's most reliable stories, and the shape of the capital is changing. Deal value roughly quintupled over a decade, and the newest activity includes platform M&A — one investment firm buying another's development-and-management capability.
That's the tell that matters. When capital buys a platform rather than a portfolio, it's underwriting a pipeline: repeatable acquisitions, development, and property management at scale. It's how an asset class graduates from opportunistic to institutional.
The demand case is unglamorous and durable. Outpatient care keeps migrating out of hospitals and into retail-adjacent medical space, and the patient base is aging into more visits. That's cash flow that doesn't ask whether workers came back to the office.
Implications
Institutional owners are treating MOB as a core, hold-forever allocation, which compresses cap rates for well-tenanted outpatient product. Sponsors with development-and-management platforms are now acquisition targets themselves. For buyers late to the beat, entry pricing is no longer cheap — the easy repricing is gone; execution and tenant health are the edge.
Key Takeaway
When investors start buying the operator instead of the building, the asset class has gone institutional.
Source: CRE Daily / CommercialSearch (PwC-ULI) · through July 2026
